Fifty 410 tirzepatide review
Advertised at $133 and billed at $133 — no gap. Position 4 of 18 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
Prepaid blocks only: $399 for three months at the starter protocol, $549 at high dose. No subscription, nothing auto-renews.
That is $133 or $183 a month. In a market built on recurring billing, a seller that takes one payment and stops is worth flagging.
The numbers
| Fifty 410 · tirzepatide | |
|---|---|
| Advertised | $133/mo |
| Membership | None |
| Billed | $133/mo |
| Advertised-to-billed gap | None |
| Per year | $1,596 |
| Board position | 4 of 18, cheapest first |
Sold only as prepaid three-month blocks: $399 for the starter protocol or $549 for high-dose. There is no month-to-month option.
Where the gap is
The gap here is between protocols, not between advert and bill: $133 is the starter, $183 is high dose, and most people end up on the second. Both are disclosed up front, and no payment is taken until a provider approves you.
Against the board
About $1,596 to $2,196 a year. Competitive at the starter protocol, mid-board at high dose.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
How the programme works
Compounded GLP-1 telehealth platform selling prepaid three-month blocks with no membership, no subscription and no recurring charges.
Verified facts
- Compounded tirzepatide starter protocol at $133/month, sold as a $399 three-month block.
- High-dose tirzepatide protocol at $183/month, sold as a $549 three-month block.
- No membership, no subscription and no recurring charges — you buy a block outright.
- Provider consultation and free 1-2 day shipping included in the price.
- States it is a telehealth platform that does not compound or distribute medication itself, and that preparations come from FDA-registered 503A pharmacies.
- Publishes unusually detailed information on 503A standards, USP 797 sterility and batch testing.
- No payment taken unless a provider approves you.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Genuinely no subscription — you buy a block and nothing recurs.
- Among the lowest tirzepatide rates verified.
- Unusually detailed public explanation of 503A standards and batch testing.
- No payment taken until a provider approves you.
Against it
- Prepaid blocks only, so there is no way to try a single month.
- Higher doses cost meaningfully more — $183/month against $133.
- Does not name the specific pharmacy, only the standards it requires.
Read this bit. The $133 is the starter protocol. Moving to the high-dose protocol takes it to $183/month, and both are prepaid three-month commitments.
Score
4.2 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 4.8 / 5 |
| Price honesty | 20% | 4.6 / 5 |
| Clinical support | 20% | 3.5 / 5 |
| Pharmacy sourcing | 15% | 4.2 / 5 |
| Cancelling | 15% | 3.3 / 5 |
Verdict
Cheap and structurally honest. Budget from $183, and note you cannot buy a single month to test tolerance.
More from the desk
- Coreage Rx tirzepatide review
Advertised at $149, billed at $199. Position 1 of 18 on our board.
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.
- Ozari Health tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.